Aridis Pharmaceuticals Inc. (ARDS) SEC filings
ARDS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ARDS overview →
5 measured ARDS SEC filing events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Aridis Pharmaceuticals, For: Jun 24 | SEC filing · Form 8-K | +13.27% | -19.42% | |
| Form 8-K Aridis Pharmaceuticals, For: Jan 12 | SEC filing · Form 8-K | +0.00% | +5.80% | |
| Form 8-K Aridis Pharmaceuticals, For: Dec 16 | SEC filing · Form 8-K | — | -15.27% | |
| Form DEFA14A Aridis Pharmaceuticals, | SEC filing · Form DEFA14A | — | -15.27% | |
| Form DEFA14A Aridis Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | -15.27% |
Keep exploring
More ARDS: earnings → · analyst actions → · ARDS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Medmira Inc (MIR_CDNX) | 31 | 0.00% | 10% |
| BIOFORCE NANOSCIENCES HLD (BFNH) | 30 | +0.30% | 50% |
| Evelo Biosciences, Inc. (EVLO) | 28 | -3.02% | 36% |
| Nu-Med Plus Inc. Com (NUMD) | 28 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.